COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,572 Articles (22,415 medRxiv, 8,157 bioRxiv)

Most recent first Previous |  Page 2628: Articles 26271-26280  | Next

Burden of COVID-19 pandemic in India: Perspectives from Health Infrastructure
Sahoo, H., Mandal, C., Mishra, S., Banerjee, S.
10.1101/2020.05.26.20113456 — Posted: 2020-05-27
To isolate, or not to isolate: a theoretical framework for disease control via contact tracing
Lunz, D., Batt, G., Ruess, J.
10.1101/2020.05.26.20113340 — Posted: 2020-05-27
Six Scenarios for non-medical interventions in the SARS-CoV-2 epidemic
Kempf, P.
10.1101/2020.05.25.20112532 — Posted: 2020-05-27
Association of the Covid-19 lockdown with smoking, drinking, and attempts to quit in England: an analysis of 2019-2020 data
Jackson, S. E., Garnett, C., Shahab, L., Oldham, M., Brown, J.
10.1101/2020.05.25.20112656 — Posted: 2020-05-27
COVID-19: The unreasonable effectiveness of simple models
Carletti, T., Fanelli, D., Piazza, F.
10.1101/2020.05.26.20110957 — Posted: 2020-05-27
Deteriorated Covid19 control due to delayed lockdown resulting from strategic interactions between Governments and oppositions.
Carrozzo Magli, A., d'Onofrio, A., Manfredi, P.
10.1101/2020.05.26.20112946 — Posted: 2020-05-27
Combining fine-scale social contact data with epidemic modelling reveals interactions between contact tracing, quarantine, testing and physical distancing for controlling COVID-19
Firth, J. A., Hellewell, J., Klepac, P., Kissler, S. M., CMMID COVID-19 working group, , Kucharski, A. J., Spurgin, L. G.
10.1101/2020.05.26.20113720 — Posted: 2020-05-27 Discussion: Offsite
THE LOW-HARM SCORE FOR PREDICTING MORTALITY IN PATIENTS DIAGNOSED WITH COVID-19: A MULTICENTRIC VALIDATION STUDY
Soto-Mota, A., Marfil Garza, B. A., Martinez Rodriguez, E., Barreto Rodriguez, J. O., Lopez Romo, A. E., Alberti Minutti, P., Alejandre Loya, J. V., Perez Talavera, F. E., Lopez-Zamora, V. N., Ramirez-Bernal, F., Avila-Cervera, F. J., Velazquez Burciaga, A. N., Morado Aramburo, O., Pina Olguin, L. A., Soto-Rodriguez, A., Castaneda Prado, A., Santillan-Doherty, P., Galindo Galindo, J. O., Hernandez Gordillo, D., Gutierrez Mejia, J.
10.1101/2020.05.26.20111120 — Posted: 2020-05-27
Single-cell RNA-seq and V(D)J profiling of immune cells in COVID-19 patients
Fan, X., Chi, X., Ma, W., Zhong, S., Dong, Y., Zhou, W., Ding, W., Fan, H., Yin, C., Zuo, Z., Yang, Y., Zhang, M., Ma, Q., Liu, J., Fang, T., Wu, Q., Chen, W., Wang, X.
10.1101/2020.05.24.20101238 — Posted: 2020-05-27 Discussion: Onsite | Offsite
The Rapid Deployment of a 3D Printed Latticed Nasopharyngeal Swab for COVID-19 Testing Made Using Digital Light Synthesis
Bennett, I., Bulterys, P. L., Chang, M., DeSimone, J. M., Fralick, J., Herring, M., Kabaria, H., Kong, C., Larson, B., Lu, O., Maxner, A., Meyer, E., Patterson, S., Pollack, S., Rolland, J., Schmidt, S., Seshadri, S., Swarup, K., Thomas, C., Van Wert, R.
10.1101/2020.05.25.20112201 — Posted: 2020-05-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).